Literature DB >> 7805892

cDNA and deduced amino acid sequence of human PK-120, a plasma kallikrein-sensitive glycoprotein.

H Nishimura1, I Kakizaki, T Muta, N Sasaki, P X Pu, T Yamashita, S Nagasawa.   

Abstract

PK-120 is a substrate for plasma kallikrein (PK), recently purified from human plasma. Here we have established the cDNA sequence for human PK-120 mRNA. The deduced amino sequence of PK-120 revealed that it consists of 902 amino acid residues with a calculated mass of 116,423 Da. The putative cleavage sites by PK have been proposed, suggesting that PK-120 may be a precursor of a bioactive peptide. Most interestingly, PK-120 showed significant sequence identities to heavy chains (HCs) of the inter-alpha-trypsin inhibitor (ITI) superfamily.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7805892     DOI: 10.1016/0014-5793(94)01364-7

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  16 in total

1.  Differential exoprotease activities confer tumor-specific serum peptidome patterns.

Authors:  Josep Villanueva; David R Shaffer; John Philip; Carlos A Chaparro; Hediye Erdjument-Bromage; Adam B Olshen; Martin Fleisher; Hans Lilja; Edi Brogi; Jeff Boyd; Marta Sanchez-Carbayo; Eric C Holland; Carlos Cordon-Cardo; Howard I Scher; Paul Tempst
Journal:  J Clin Invest       Date:  2006-01       Impact factor: 14.808

Review 2.  The inter-alpha-inhibitor family: from structure to regulation.

Authors:  J P Salier; P Rouet; G Raguenez; M Daveau
Journal:  Biochem J       Date:  1996-04-01       Impact factor: 3.857

3.  ITIH4 and Gpx3 are potential biomarkers for amyotrophic lateral sclerosis.

Authors:  Hirotaka Tanaka; Masamitsu Shimazawa; Masafumi Takata; Hideo Kaneko; Kazuhiro Tsuruma; Tsunehiko Ikeda; Hitoshi Warita; Masashi Aoki; Mitsunori Yamada; Hitoshi Takahashi; Isao Hozumi; Hiroshi Minatsu; Takashi Inuzuka; Hideaki Hara
Journal:  J Neurol       Date:  2013-02-23       Impact factor: 4.849

Review 4.  Glycoprotein disease markers and single protein-omics.

Authors:  Kevin Chandler; Radoslav Goldman
Journal:  Mol Cell Proteomics       Date:  2013-02-11       Impact factor: 5.911

5.  Irreversible heavy chain transfer to hyaluronan oligosaccharides by tumor necrosis factor-stimulated gene-6.

Authors:  Mark E Lauer; Tibor T Glant; Katalin Mikecz; Paul L DeAngelis; F Michael Haller; M Elaine Husni; Vincent C Hascall; Anthony Calabro
Journal:  J Biol Chem       Date:  2012-11-19       Impact factor: 5.157

6.  Molecular cloning of membrane cofactor protein (MCP; CD46) on B95a cell, an Epstein-Barr virus-transformed marmoset B cell line: B95a-MCP is susceptible to infection by the CAM, but not the Nagahata strain of the measles virus.

Authors:  Y Murakami; T Seya; M Kurita; A Fukui; S Ueda; S Nagasawa
Journal:  Biochem J       Date:  1998-03-15       Impact factor: 3.857

7.  Hypercholesterolemia associated with splice-junction variation of inter-alpha-trypsin inhibitor heavy chain 4 (ITIH4) gene.

Authors:  Yuko Fujita; Yoichi Ezura; Mitsuru Emi; Keiko Sato; Daisuke Takada; Yasuhiko Iino; Yasuo Katayama; Kaneo Takahashi; Kouhei Kamimura; Hideaki Bujo; Yasushi Saito
Journal:  J Hum Genet       Date:  2003-12-06       Impact factor: 3.172

8.  Specific Investigation of Sample Handling Effects on Protease Activities and Absolute Serum Concentrations of Various Putative Peptidome Cancer Biomarkers.

Authors:  Irene van den Broek; Rolf W Sparidans; Jan H M Schellens; Jos H Beijnen
Journal:  Clin Proteomics       Date:  2010-09-30       Impact factor: 3.988

9.  Domain structure of bi-functional selenoprotein P.

Authors:  Yoshiro Saito; Noriko Sato; Masaki Hirashima; Gen Takebe; Shigeharu Nagasawa; Kazuhiko Takahashi
Journal:  Biochem J       Date:  2004-08-01       Impact factor: 3.857

10.  Thrombin Cleavage of Inter-α-inhibitor Heavy Chain 1 Regulates Leukocyte Binding to an Inflammatory Hyaluronan Matrix.

Authors:  Aaron C Petrey; Carol A de la Motte
Journal:  J Biol Chem       Date:  2016-09-27       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.